GANDEEVA THERAPEUTICS
Gandeeva Therapeutics has developed a proprietary platform that combines innovative technologies across biochemistry, structural biology, imaging and machine learning to characterize protein-drug interactions at the atomic level, all designed to provide new insights into targeting protein function.
GANDEEVA THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2021-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.gandeeva.com
Total Employee:
11+
Status:
Active
Contact:
778-731-1022
Total Funding:
40 M USD
Similar Organizations
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Employees Featured
Founder
Investors List
Leaps by Bayer
Leaps by Bayer investment in Series A - Gandeeva Therapeutics
Obvious Ventures
Obvious Ventures investment in Series A - Gandeeva Therapeutics
Lux Capital
Lux Capital investment in Series A - Gandeeva Therapeutics
Amgen Ventures
Amgen Ventures investment in Series A - Gandeeva Therapeutics
Amplitude Venture Capital
Amplitude Venture Capital investment in Series A - Gandeeva Therapeutics
Air Street Capital
Air Street Capital investment in Series A - Gandeeva Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-20 | Gandeeva Therapeutics announces search for new Chief Strategy Development Officer |
Official Site Inspections
http://www.gandeeva.com
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gandeeva Therapeutics"
Gandeeva Therapeutics - Crunchbase Company Profile …
Jan 31, 2022 Gandeeva has a robust preclinical oncology pipeline targeting difficult-to-treat cancers with novel protein interaction modulators such as interfacial glues (iGluesâ„¢) and allosteric inhibitors. Gandeeva is …See details»
Team - Gandeeva Therapeutics
Team We are an interdisciplinary team of thinkers and doers working together to create better medicines LEADERSHIP BOARD SCIENTIFIC ADVISORY BOARD STAFF Leadership …See details»
UBC Medicine spin-off company raises US$40m to …
Feb 7, 2022 British Columbia is proving once again that it is a leading global hub for biotech innovation. Gandeeva Therapeutics, a UBC spin-off company led by Faculty of Medicine professor Dr. Sriram Subramaniam, recently announced …See details»
Gandeeva Raises $40M in Series A Funding to Develop …
Gandeevaâ„¢ is a precision biotechnology company harnessing the power of cryo-electron microscopy (cryo-EM) and machine learning to advance drug discovery and development at scale. Gandeeva Founder and CEO, Sriram …See details»
Gandeeva Therapeutics - LinkedIn
Gandeeva Therapeutics is a precision biotechnology company integrating the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop differentiated therapeutics by …See details»
Gandeeva Therapeutics Company Profile 2024: Valuation, Funding ...
Gandeeva Therapeutics General Information Description. Operator of a drug discovery biotechnology company intended to integrate the power of cryogenic electron microscopy and …See details»
Gandeeva Therapeutics - Funding, Financials, Valuation & Investors
Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues. Search Crunchbase. ... How much funding has this …See details»
Gandeeva Raises $40M in Series A Funding to Develop Novel …
Jan 31, 2022 About Gandeeva Therapeutics, Inc. Gandeevaâ„¢ is a precision biotechnology company harnessing the power of cryo-electron microscopy (cryo-EM) and machine learning …See details»
Gandeeva Therapeutics - Life Sciences British Columbia
Aug 7, 2024 Gandeeva Therapeutics is a precision biotechnology company integrating the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop …See details»
Biotech firm leveraging AI to analyze protein interactions launches ...
Jan 31, 2022 Gandeeva’s platform generates 200-300 molecules instead of 3,000, so they are able to identify potential drug candidates in two-three years instead of 5-6, thereby shortening …See details»
Protein-Drug Precision Imaging Company Gandeeva Raises $40M …
Feb 2, 2022 Vancouver, B.C.-based Gandeeva Therapeutics, a precision medicine company leveraging cryogenic electron microscopy (cryo-EM) with artificial intelligence (AI) and …See details»
B.C. biotech Gandeeva raises US$40m to advance drug discovery
Jan 31, 2022 B.C.’s bustling biotech sector is getting another big capital injection. Gandeeva Therapeutics Inc. announced Monday the close of a US$40-million Series A round aimed at …See details»
Gandeeva Raises $40M in Series A Funding to Develop Novel …
Jan 31, 2022 VANCOUVER, B.C. — Gandeeva Therapeutics, a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine …See details»
Gandeeva and Moderna Enter into Cryo-EM ... - Gandeeva …
Mar 30, 2023 VANCOUVER, BC – Gandeeva Therapeutics, Inc., a precision medicine company focused on designing and developing novel therapeutics guided by cryogenic electron …See details»
Vancouver-based Gandeeva Raises $51 Million Series-A Funding …
Jan 31, 2022 Gandeeva Therapeutics, a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop novel …See details»
Gandeeva and Moderna Enter into Cryo-EM Research …
Mar 30, 2023 Under the research agreement, Gandeeva and Moderna will study and validate the application of Gandeeva’s proprietary cryo-EM platform approach for an undisclosed …See details»
Gandeeva Therapeutics — unlocking the power of cryo-EM
Jan 31, 2022 Gandeeva is another fantastic example of a company at the bleeding edge of its field with global ambitions and access to local resources such as the world-class cryo-EM …See details»
Gandeeva Raises $40M to Develop Novel Therapies Based on …
Feb 7, 2022 Gandeeva Therapeutics, a precision biotechnology company, announced that it had raised $40 million in Series A funding on Jan. 31, 2022. This funding will go toward research …See details»
News - Gandeeva Therapeutics
Apr 19, 2022 Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors January 24, 2023 Gandeeva Therapeutics Announces Formation of …See details»